Navigating Regulatory Hurdles in Drug Development
DrugBank
JUNE 18, 2025
In 2020, the FDA halted Johnson & Johnson’s COVID-19 vaccine production at a contract manufacturing facility after discovering quality control issues. Regulatory bodies require strict adherence to Good Manufacturing Practices (GMPs) to ensure that drugs are consistently produced at high quality.
Let's personalize your content